4 results
Not approvedWill not start
Change from baseline in regional cerebral blood flow in response to various visual stimuli ascertained by Positron Emission Tomography scan after 8 weeks of flibanserin 100 mg treatment.
Approved WMORecruiting
The purpose of this study is to explore the efficacy and safety of LTP001 in participants with WHO Group 1 pulmonary hypertension (PH), also referred to as Pulmonary Arterial Hypertension (PAH).This proof of concept study will be executed as theā¦
Approved WMORecruiting
The purpose of the study is to look at how well the study treatment works in participants with idiopathic pulmonary fibrosis.
Approved WMOPending
To assess the long term safety of LTP001 in participants with pulmonary arterial hypertension (PAH).